Data-driven policy promoting innovation and access.
Pioneer’s Life Sciences Initiative (PLSI) is a nationally recognized authority on life sciences policy, working in Washington, D.C., and in more than 20 states. Leveraging a team of experts from around the country, PLSI strengthens the policies that drive biomedical innovation and expand patient access.
Our work draws on extensive experience with QALY analysis, economic modeling, patent protections, FDA pathways, gene therapies, pricing and price controls, pharmacy benefit managers, out-of-pocket affordability issues, and federal drug pricing programs such as 340B.
Informed by deep expertise in regions like Massachusetts—home to the world’s leading life sciences cluster—where industry, universities, hospitals, and nonprofits come together to advance discovery and set standards for excellence, we aim to keep the United States a global leader in developing breakthrough therapies and ensuring patients have access to them.
Philanthropic support fuels our ability to deliver bold ideas, rigorous research, and real-world impact—advancing solutions that shape policy and strengthen communities.
In 2024, Massachusetts has the second lowest homicide rate in the nation, at 2 homicides per 100K population. Only Hawaii is lower (1.6). The highest rates were in DC (25.5) and New Mexico (13.1). Find this data on Pioneer’s new US DataLabs website! https://loom.ly/U4Y1-ow
